8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide
C138H98B2Br2Cl2F12N24O10 — CID 159499750
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide
8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide (PubChem CID 159499750) has the molecular formula C138H98B2Br2Cl2F12N24O10 and a molecular weight of 2732.77 g/mol. Its IUPAC name is 8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide.
Molecular Properties
| Compound Name | 8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide |
|---|---|
| PubChem CID | 159499750 |
| Molecular Formula | C138H98B2Br2Cl2F12N24O10 |
| Molecular Weight | 2732.77 g/mol |
| Exact Mass | 2728.56 |
| IUPAC Name | 8-bromo-6-chloroimidazo[1,2-b]pyridazine;5-(3-bromoimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;5-(6-chloroimidazo[1,2-b]pyridazin-8-yl)-N-(4-fluorophenyl)-2-methylbenzamide;(2,3-difluorophenyl)boronic acid;bis(5-[3-(2,3-difluorophenyl)imidazo[1,2-b]pyridazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide);[3-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]boronic acid;N-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-8-yl-2-methylbenzamide |
| SMILES | Cc1ccc(-c2cc(Cl)nn3ccnc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(-c2ccnn3c(-c4cccc(F)c4F)cnc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(-c2ccnn3c(-c4cccc(F)c4F)cnc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(-c2ccnn3c(Br)cnc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(-c2ccnn3ccnc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(B(O)O)cc1C(=O)Nc1ccc(F)cc1.Clc1cc(Br)c2nccn2n1.OB(O)c1cccc(F)c1F |
| InChI | InChI=1S/2C26H17F3N4O.C20H14BrFN4O.C20H14ClFN4O.C20H15FN4O.C14H13BFNO3.C6H5BF2O2.C6H3BrClN3/c2*1-15-5-6-16(13-21(15)26(34)32-18-9-7-17(27)8-10-18)19-11-12-31-33-23(14-30-25(19)33)20-3-2-4-22(28)24(20)29;1-12-2-3-13(16-8-9-24-26-18(21)11-23-19(16)26)10-17(12)20(27)25-15-6-4-14(22)5-7-15;1-12-2-3-13(17-11-18(21)25-26-9-8-23-19(17)26)10-16(12)20(27)24-15-6-4-14(22)5-7-15;1-13-2-3-14(17-8-9-23-25-11-10-22-19(17)25)12-18(13)20(26)24-16-6-4-15(21)5-7-16;1-9-2-3-10(15(19)20)8-13(9)14(18)17-12-6-4-11(16)5-7-12;8-5-3-1-2-4(6(5)9)7(10)11;7-4-3-5(8)10-11-2-1-9-6(4)11/h2*2-14H,1H3,(H,32,34);2-11H,1H3,(H,25,27);2-11H,1H3,(H,24,27);2-12H,1H3,(H,24,26);2-8,19-20H,1H3,(H,17,18);1-3,10-11H;1-3H |
| InChIKey | LZFRIFKBCWJCCN-UHFFFAOYSA-N |
| XLogP | 28.64 |
| TPSA | 436.66 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 190 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2732.77 |
| LogP ≤ 5 | 28.64 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 28 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159499750 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.